Allergan Plc (AGN):企業の財務・戦略的SWOT分析

【英語タイトル】Allergan Plc (AGN) - Financial and Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(DATA904C14038)・商品コード:DATA904C14038
・発行会社(調査会社):GlobalData
・発行日:2019年2月
・ページ数:70
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Allergan Plc (AGN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Allergan Plc (Allergan) is a specialty pharmaceutical company that develops and sells branded pharmaceuticals, biosimilar and over-the-counter (OTC) pharmaceutical products. It offers products in the areas of eye care, medical aesthetics, dermatology, central nervous system, gastroenterology, women’s health, urology and anti-infective therapeutic categories. The company sells its products to retailers, drug wholesalers and distributors, including national retail drug and food store chains, mail order retailers, hospitals, clinics, government agencies and managed healthcare providers such as health maintenance organizations and other institutions. It has operations in several countries across the Americas, Europe, Asia-Pacific, the Middle East and Africa. Allergan is headquartered in Dublin, Ireland.

Allergan Plc Key Recent Developments

Feb 19,2019 Teva finalizes settlement with Federal Trade Commission to resolve all outstanding litigation between the parties
Feb 19,2019 Allergan names Robert J. Hugin as board director
Feb 19,2019 FTC enters global settlement to resolve reverse-payment charges against Teva
Jan 29,2019 Allergan reports fourth quarter and full-year 2018 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Allergan Plc – Key Facts
Allergan Plc – Key Employees
Allergan Plc – Key Employee Biographies
Allergan Plc – Major Products and Services
Allergan Plc – History
Allergan Plc – Company Statement
Allergan Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Allergan Plc – Business Description
Business Segment: International Brands Segment
Overview
Performance
Business Segment: US General Medicine Segment
Overview
Performance
Business Segment: US Specialized Therapeutics Segment
Overview
Performance
R&D Overview
Allergan Plc – Corporate Strategy
Allergan Plc – SWOT Analysis
SWOT Analysis – Overview
Allergan Plc – Strengths
Allergan Plc – Weaknesses
Allergan Plc – Opportunities
Allergan Plc – Threats
Allergan Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Allergan Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Allergan Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Allergan Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 19, 2019: Teva finalizes settlement with Federal Trade Commission to resolve all outstanding litigation between the parties
Feb 19, 2019: Allergan names Robert J. Hugin as board director
Feb 19, 2019: FTC enters global settlement to resolve reverse-payment charges against Teva
Jan 29, 2019: Allergan reports fourth quarter and full-year 2018 financial results
Jan 24, 2019: Amgen And Allergan Announce Positive TopLine Results From Phase 1 Phase 3 Study Of ABP 798 Biosimilar Candidate To Rituximab
Jan 07, 2019: Allergan Establishes R&D Center in Kendall Square to Open in Q1 2019
Jan 07, 2019: Allergan to establish R&D presence in Cambridge, Massachusetts
Jan 03, 2019: Ironwood and Allergan Announce Settlement with Mylan Resolving LINZESSÂ linaclotide Patent Litigation
Dec 19, 2018: Allergan suspends sales and withdraws supply of textured breast implants in European markets
Nov 26, 2018: Allergan makes new appointments to Finance leadership team
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Allergan Plc, Key Facts
Allergan Plc, Key Employees
Allergan Plc, Key Employee Biographies
Allergan Plc, Major Products and Services
Allergan Plc, History
Allergan Plc, Other Locations
Allergan Plc, Subsidiaries
Allergan Plc, Key Competitors
Allergan Plc, Ratios based on current share price
Allergan Plc, Annual Ratios
Allergan Plc, Annual Ratios (Cont...1)
Allergan Plc, Annual Ratios (Cont...2)
Allergan Plc, Interim Ratios
Allergan Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Allergan Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Allergan Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Allergan Plc, Performance Chart (2014 - 2018)
Allergan Plc, Ratio Charts
Allergan Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Allergan Plc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★調査レポート[Allergan Plc (AGN):企業の財務・戦略的SWOT分析] (コード:DATA904C14038)販売に関する免責事項を必ずご確認ください。
★調査レポート[Allergan Plc (AGN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆